As compared to NAFLD-DIOS in our cohort, we found a somewhat lower hepcidin-to-ferritin and hepcidin-to-iron score ratios in patients with alcoholic liver disease and hepatitis C, although the present study was underpowered to detect a true difference in this regard. The gene discussed is HAMP; the disease is metabolic dysfunction-associated steatotic liver disease.